Literature DB >> 8506417

The histopathology of cutaneous malignant melanoma.

R L Barnhill1, M C Mihm.   

Abstract

The vast majority of cutaneous malignant melanomas (CMM) develop from a proliferation of intraepidermal melanocytes that may progress through radial (including in situ and microinvasive stages) and vertical growth phases (VGP). The currently accepted classification of melanoma is based on the presence (eg, superficial spreading, lentigo maligna, or acral lentiginous melanoma) or absence of a radial growth phase (nodular melanoma). Although not standardized, melanoma may also be classified as to the nature of the VGP, eg, as expansile nodules composed of epithelioid cells, spindle cells, or smaller nevus-like cells supervening on one of the radial growth components previously mentioned, or developing de novo. Less common variants of the VGP include desmoplastic and neurotropic melanomas (often arising with lentiginous melanomas), and the controversial (and perhaps mainly conceptual) entity, minimal deviation melanoma. Other unusual or rare forms of melanoma are malignant blue nevus, balloon cell melanoma, and clear cell sarcoma. An extensive discussion of the differential diagnosis of the various types of melanoma is provided.

Entities:  

Mesh:

Year:  1993        PMID: 8506417

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  10 in total

1.  Melanoma : A Frequently Missed Diagnosis.

Authors:  R Lakhtakia; A Mehta; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

3.  Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Authors:  Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

Review 4.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

5.  RSK1 activation promotes invasion in nodular melanoma.

Authors:  Amel Salhi; Joshua A Farhadian; Keith M Giles; Eleazar Vega-Saenz de Miera; Ines P Silva; Caitlin Bourque; Karen Yeh; Sagar Chhangawala; Jinhua Wang; Fei Ye; David Y Zhang; Eva Hernando-Monge; Yariv Houvras; Iman Osman
Journal:  Am J Pathol       Date:  2015-01-08       Impact factor: 4.307

6.  Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

Authors:  A Mackensen; G Carcelain; S Viel; M C Raynal; H Michalaki; F Triebel; J Bosq; T Hercend
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology.

Authors:  Anna Batistatou; Martin G Cook; Daniela Massi
Journal:  Virchows Arch       Date:  2009-04-08       Impact factor: 4.064

8.  Only superficial spreading melanoma is causing the melanoma epidemics?

Authors:  E Crocetti; P Carli
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

9.  Expression of microphthalmia transcription factor, S100 protein, and HMB-45 in malignant melanoma and pigmented nevi.

Authors:  Jianxin Xia; Yanlong Wang; Fuqiu Li; Jinfeng Wang; Yan Mu; Xianglin Mei; Xue Li; Wenjing Zhu; Xianhua Jin; Kai Yu
Journal:  Biomed Rep       Date:  2016-08-01

10.  Chondrosarcomatous Differentiation in a Large Malignant Melanoma of the Scalp.

Authors:  Colin S Alderson; Helen E Douglas; Rebecca Rollett; Bipin Mathew; Paolo Matteucci
Journal:  Case Rep Med       Date:  2016-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.